Navigation Links
DrugRisks Update: Warning Added to Pradaxa For Blood Condition
Date:5/8/2013

Chicago, IL (PRWEB) May 08, 2013

The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. The maker of the drug recently updated label warnings to include the risk of a blood platelet disorder*.

DrugRisks was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Health experts have disagreed over whether Pradaxa has higher risks of internal bleeding than traditional anticoagulants. The FDA has stated the drug is as safe as warfarin**. However, the Institute for Safe Medication Practices recently ranked drugs like Pradaxa among the most dangerous, and warned that Pradaxa bleeding may be 5 times as likely to result in death than bleeding from warfarin or Coumadin***.

The resource center has also added a study from the University of Illinois at Chicago suggesting the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than expected****.

Now, DrugRisks has learned that the maker of the drug, Boehringer Ingelheim, recently added a new Pradaxa side effect warning to the label advising of the risk of thrombocytopenia, a drop in blood platelets that can result in Pradaxa internal bleeding*.

With a growing number of patients filing a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Due to the specialized nature of federal drug injury cases, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Boehringer Ingelheim, 4/30/13; us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2013/04-30-13-boehringer-ingelheim-pharmaceuticals-prescribing-information-pradaxa-dabigatran-etexilate-mesylate.html
**FDA 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****New England Journal of Medicine, 4/4/13; nejm.org/doi/full/10.1056/NEJMp1302834

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/side-effects/prweb10709493.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
2. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
3. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
4. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
5. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
6. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
7. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
8. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
9. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
10. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
11. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: